Statistics

Total Visits

Views
LONG-TERM (104-WEEK) EFFICACY AND SAFETY PROFILE OF APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A PHASE III, RANDOMIZED, CONTROLLED TRIAL AND OPEN-LABEL EXTENSION (PALACE 1)71

Select a period of time:

Number of views in the range

Views
LONG-TERM (104-WEEK) EFFICACY AND SAFETY PROFILE OF APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A PHASE III, RANDOMIZED, CONTROLLED TRIAL AND OPEN-LABEL EXTENSION (PALACE 1)42

Views

Views
March 202514
April 202513
May 20250
June 20252
July 202513
August 20250
September 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States14
Singapore12
Hong Kong10
Brazil4
Spain1
Morocco1
 

Top cities views

Views
Hong Kong10
Ashburn1
Brunswick1
Chicago1
Council Bluffs1
Cruzeiro1
Douglasville1
Greer1
Houston1
Inhambupe1